Primary record
Nevirapine Anhydrous; 6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- (9CI); BI-RG 587; NSC 641530; Nevarapine; Nevirapine; Viramune
- 库存
- 6,252 克
- 纯度
- 98.6 %
- CAS
- 129618-40-2
化合物标识与属性
- CAS
- 129618-40-2
- PubChem CID
- 4463
- SMILES
- CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
- Canonical SMILES
- Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1
名称与同义词
- nevirapine
- Viramune
- 129618-40-2
- Nevirapine anhydrous
- Viramune XR
- Nevirapine teva
- Nevirapina
- BI-RG-587
- nevirapinum
- Nevirapine-d3
- Nevirapine, anhydrous
- Nevirapine)
- Viramune(TM)
- Nevirapine RS
- Viramune (TN)
- Viramune IR
- Nevirapine-D4
- 1vrt
- 2hny
- Nevirapinum anhydrous
- BIRG 0587
- BIRG587
- Nevirapine [USAN:INN]
- NEVARAPINE
- Nevirapine hemihydrate
- Nevirapine & CD4-IgG
- CHEMBL57
- Nevirapine (Standard)
- Nevirapine (Viramune)
- Nevirapine (anhydrous)
- 99DK7FVK1H
- BIRG-0587
- Hemihydrate, Nevirapine
- Nevirapine & PRO 140
- NEVIRAPINE [MI]
- Opera_ID_934
- UNII-99DK7FVK1H
- BI-RG 587
- C15H14N4O
- NEVIRAPINE [INN]
- NEVIRAPINE [JAN]
- Viramune;BI-RG 587
- RefChem:853798
- BIRG-587
- BIRG0587
- NEVIRAPINE [HSDB]
- NEVIRAPINE [USAN]
- Nevirapine (JAN/USP/INN)
- DTXSID7031797
- MFCD00866928
- NEVIRAPINE [VANDF]
- CHEBI:63613
- D0O2EM
- Epitope ID:231711
- HSDB 7164
- MLS000084585
- Nevirapine (anhydrous) CRS
- NEVIRAPINE [MART.]
- Promeco Brand of Nevirapine
- SCHEMBL3318
- BIRG 587
- NEVIRAPINE [WHO-DD]
- DTXCID9010787
- BI RG 587
- MLS000759409
- MLS001055309
- MLS001201730
- MLS001424058
- MLS006011423
- BIDD:GT0326
- NEVIRAPINE [EMA EPAR]
- NSC-641530
- NQDJXKOVJZTUJA-UHFFFAOYSA-N
- NSC641530
- AC1L1I81
- BDBM1434
- Nevirapine [USAN:USP:INN:BAN]
- orb1308075
- ZINC4778
- BI-RG-587 & CD4-IgG
- NEVIRAPINE [ORANGE BOOK]
- NSC 641530
- SCHEMBL29393780
- SCHEMBL29614675
- SCHEMBL30267890
- CTK8E7455
- GTPL12676
- KS-00000KZF
- 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
- CID4463
- J05AG01
- NEVIRAPINE [EP MONOGRAPH]
- NEVIRAPINE [USP IMPURITY]
- NVP
- Nevirapine for peak identification
- HMS2051J09
- HMS2231O23
- HMS3264D21
- HMS3371E03
- HMS3393J09
- HMS3655I08
- HMS3715B10
- HMS5079D22
- NEVIRAPINE [USP MONOGRAPH]
- Pharmakon1600-01503842
- ALBB-027264
- BCP05587
- BSB41895
- DRG-0116
- MSK10168
- Viramune, BI-RG 587, Nevirapine
- Tox21 110982
- Tox21_110982
- Tox21_200770
- AC-643
- AC1280
- BBL010768
- C15-H14-N4-O
- EBC-11254
- HY-10570R
- NCGC00065890-02
- NP3489
- NSC759902
- STK580320
- NEVIRAPINE ANHYDROUS [USP-RS]
- NEVIRAPINE ANHYDROUS [WHO-IP]
- NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
- SMR000048458
- 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
- AKOS005504351
- Nevirapine for peak identification CRS
- Tox21_110982_1
- AB07544
- Cahill May Roberts Brand of Nevirapine
- CCG-100939
- CS-2252
- DB00238
- KS-5019
- LS-2289
- NC00189
- NN15304
- NSC-759902
- RL01415
- 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
- NCGC00065890-03
- NCGC00065890-04
- NCGC00065890-05
- NCGC00065890-07
- NCGC00065890-14
- NCGC00258324-01
- S1742
- AJ-08226
- AK143126
- AN-15635
- BC206673
- CPD000048458
- H954
- HY-10570
- Nevirapine 100 microg/mL in Acetonitrile
- SAM001246551
- SC-17266
- SY009679
- ZB000592
- BI-RG 587;NSC 641530;NVP
- AB0013383
- AB2000266
- DB-041930
- J420.601K
- RT-014690
- A8481
- CAS-129618-40-2
- FT-0607215
- FT-0672686
- N0922
- NEVIRAPINE TABLETS FOR ORAL SUSPENSION
- NEVIRAPINUM ANHYDROUS [WHO-IP LATIN]
- NS00004959
- R3924
- ST24038235
- SW197569-2
- 11-Cyclopropyl-4-methyl-5H-dipyrido[3,2-b
- (S)-Ethyl 3-Hydroxy-4,4,4-Trifluorobutyrate
- 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
- 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE
- A10639
- C07263
- D00435
- EN300-119500
- AB00393001-13
- AB00393001-15
- AB00393001_16
- AB00393001_17
- NEV
- 618N402
- 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
- F358078
- Q263713
- A1199007
- I02-0310
- BRD-K15502390-001-19-1
- BRD-K15502390-001-20-9
- 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- F2173-0607
- Z1521553473
- 5-Chloro-6-iodo-1H-pyrrolo[2,3-b]pyridine-4-carbaldehyde
- 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- 11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one
- 1051419-24-9
- 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
- BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; NSC 641530; NVP
- N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
- Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard
- Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard
- Nevirapine solution, 1.0 mg/mL in methanol, certified reference material
- Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material
- 1-Methyl-5-cyclopropyl-4,5,6,11-tetraaza-5H-dibenzo[a,d]cycloheptene-10(11H)-one
- 11-Cyclopropyl-4-methyl-11H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepine-6(5H)-one
- 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one
- 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one
- 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
- 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one
- 4-amino-1-((2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl)pyrimidin-2-one
- 4-amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]pyrimidin-2-one
- 4-Methyl-11-cyclopropyl-11H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepine-6(5H)-one
- 5-Cyclopropyl-9-methyl-4,5,6,10-tetraaza-5H-dibenzo[a,d]cycloheptene-11(10H)-one
- 5H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 5,11-dihydro-11-cyclopropyl-4-methyl-
- 6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
- Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard
- Nevirapine, 99%, Non-nucleoside reverse transcriptase inhibitor (NNRTI) - 100MG 100mg
- 1051418-95-1
- 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one
- 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
- 1246088-64-1
- 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-10-one
- 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0,3,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
- 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
- 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
- 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- 4-Methyl-11-cyclopropyl-5,11-dihydro-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
- 5,11-Dihydro-11-cyclopropyl-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
- 603-345-0
- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-
- Nevirapine Anhydrous; 6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- (9CI); BI-RG 587; NSC 641530; Nevarapine; Nevirapine; Viramune